Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Advanced PET Imaging Network (APIN) is a specialized healthcare provider focused on delivering high-quality Positron Emission Tomography (PET) and Computed Tomography (CT) services. Based in Philadelphia and closely affiliated with the University of Pennsylvania Health System (Penn Medicine), the network operates multiple imaging centers across the region. APIN provides critical diagnostic support for oncology, neurology, and cardiology, utilizing a wide array of advanced radiopharmaceuticals. Beyond clinical diagnostics, the network is a key collaborator in clinical research, offering standardized imaging protocols for pharmaceutical and biotechnology trials. Their services facilitate the early detection of diseases, treatment planning, and the monitoring of therapeutic efficacy. By integrating state-of-the-art technology with academic expertise, APIN remains at the forefront of molecular imaging and precision medicine.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Advanced PET Imaging Network.